$97 Million is the total value of Healthcare Value Capital, LLC's 45 reported holdings in Q4 2011. The portfolio turnover from Q3 2011 to Q4 2011 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2011 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2012-07-25
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
PFIZER INC | 19 | Q3 2021 | 17.9% |
TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-16 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-15 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-14 |
SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.